Crossref
Combined Inhibition of EZH2 and HMGA1 Affects Gastric Carcinoma Cell Viability
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.081574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Marco De Martino und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Martino, M. D., Franco, V., Pellecchia, S., Iaccarino, A., Vecchione, M. A., Marrone, L., Chieffi, P., Spirito, L., Fusco, A., Pallante, P., & Esposito, F. (2026). Combined Inhibition of EZH2 and HMGA1 Affects Gastric Carcinoma Cell Viability. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.081574
Vancouver
Martino MD, Franco V, Pellecchia S, Iaccarino A, Vecchione MA, Marrone L, et al. Combined Inhibition of EZH2 and HMGA1 Affects Gastric Carcinoma Cell Viability. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.081574
BibTeX
@article{Martino2026,
author = {Martino, Marco De and Franco, Viviana and Pellecchia, Simona and Iaccarino, Antonino and Vecchione, Marialuisa Alessandra and Marrone, Laura and Chieffi, Paolo and Spirito, Lorenzo and Fusco, Alfredo and Pallante, Pierlorenzo and Esposito, Francesco},
title = {Combined Inhibition of EZH2 and HMGA1 Affects Gastric Carcinoma Cell Viability},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.081574}
}
EUVIMED